22S-Butyl-1α,24R-dihydroxyvitamin D3: Recovery of vitamin D receptor agonistic activity

被引:14
作者
Inaba, Yuka [1 ,2 ]
Nakabayashi, Makoto [2 ]
Itoh, Toshimasa [1 ]
Yoshimoto, Nobuko [1 ]
Ikura, Teikichi [2 ]
Ito, Nobutoshi [2 ]
Shimizu, Masato [2 ]
Yamamoto, Keiko [1 ]
机构
[1] Showa Pharmaceut Univ, Lab Drug Design & Med Chem, Tokyo 1948543, Japan
[2] Tokyo Med & Dent Univ, Sch Biomed Sci, Bunkyo Ku, Tokyo 1138510, Japan
关键词
X-ray crystallography; Coactivator; Nuclear receptor; Hydrophobic interaction; Antagonist; LIGAND-BINDING DOMAIN; BIOLOGICAL-ACTIVITIES; ANALOGS; GEMINI;
D O I
10.1016/j.jsbmb.2010.02.033
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We recently reported that 22S-butyl-1 alpha,24R-dihydroxyvitamin D-3 3 recovers the agonistic activity for vitamin D receptor (VDR), although its 25,26,27-trinor analog 2 is a potent VDR antagonist. To investigate the structural features involved in the recovery of agonism, we crystallized the ternary complex of VDR-ligand-binding domain, ligand 3 and coactivator peptide, and conducted X-ray crystallographic analysis of the complex. Compared with the complex with 2, the complex with 3 recovered the following structural features: a pincer-type hydrogen bond between the 24-hydroxyl group and VDR, the conformation of Leu305, the positioning of His301 and His393, the stability of the complex, and intimate hydrophobic interactions between the ligand and helix 12. In addition, we evaluated the potency of both compounds for recruiting RXR and coactivator. The results indicate that the complex with 3 generates a suitable surface for coactivator recruitment. These studies suggest that the action of 2 as an antagonist is caused by the generation of a surface not suitable for coactivator recruitment due to the lack of hydrophobic interactions with helix 12 as well as insufficient hydrogen bond formation between the 24-hydroxyl group and VDR. We concluded that the action of 3 as an agonist is based on the elimination of these structural defects in the complex with 2. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:146 / 150
页数:5
相关论文
共 11 条
[1]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[2]   Structural investigation of the ligand binding domain of the zebrafish VDR in complexes with 1α,25(OH)2D3 and Gemini:: purification, crystallization and preliminary X-ray diffraction analysis [J].
Ciesielski, F ;
Rochel, N ;
Mitschler, A ;
Kouzmenko, A ;
Moras, D .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2004, 89-90 (1-5) :55-59
[3]   Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: Remodelling the LBP with one side chain rotation [J].
Ciesielski, Fabrice ;
Rochel, Natacha ;
Moras, Dino .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 103 (3-5) :235-242
[4]  
Feldman D, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P1
[5]   A New Class of Vitamin D Analogues that Induce Structural Rearrangement of the Ligand-Binding Pocket of the Receptor [J].
Inaba, Yuka ;
Yoshimoto, Nobuko ;
Sakamaki, Yuta ;
Nakabayashi, Makoto ;
Ikura, Teikichi ;
Tamamura, Hirokazu ;
Ito, Nobutoshi ;
Shimizu, Masato ;
Yamamoto, Keiko .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (05) :1438-1449
[6]   Novel vitamin D3 analogs, 1α, 25(OH)2D3-26, 23-lactam (DLAMs), antagonize bone resorption via suppressing RANKL expression in osteoblasts [J].
Inada, Masaki ;
Tsukamoto, Kazuki ;
Hirata, Michiko ;
Takita, Morichika ;
Nagasawa, Kazuo ;
Miyaura, Chisato .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 372 (03) :434-439
[7]   Creative synthesis of novel vitamin D analogs for health and disease [J].
Kittaka, Atsushi ;
Saito, Nozomi ;
Honzawa, Shinobu ;
Takenouchi, Kazuya ;
Ishizuka, Seiichi ;
Chen, Tai C. ;
Peleg, Sara ;
Kato, Shigeaki ;
Arai, Midori A. .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2007, 103 (3-5) :269-276
[8]   Molecular mechanism of the vitamin D antagonistic actions of (23S)-25-dehydro-1α-hydroxyvitamin D3-26,23-lactone depends on the primary structure of the carboxyl-terminal region of the vitamin D receptor [J].
Ochiai, E ;
Miura, D ;
Eguchi, H ;
Ohara, S ;
Takenouchi, K ;
Azuma, Y ;
Kamimura, T ;
Norman, AW ;
Ishizuka, S .
MOLECULAR ENDOCRINOLOGY, 2005, 19 (05) :1147-1157
[9]   Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide [J].
Vanhooke, JL ;
Benning, MM ;
Bauer, CB ;
Pike, JW ;
DeLuca, HF .
BIOCHEMISTRY, 2004, 43 (14) :4101-4110
[10]   22-alkyl-20-epi-1α,25-dihydroxyvitamin D3 compounds of superagonistic activity:: Syntheses, biological activities and interaction with the receptor [J].
Yamamoto, Keiko ;
Inaba, Yuka ;
Yoshimoto, Nobuko ;
Choi, Mihwa ;
DeLuca, Hector F. ;
Yamada, Sachiko .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (05) :932-939